GN
Genelux Corporation (GNLX)
NASDAQ·Healthcare·Biotechnology
$2.83
-3.08%
Mkt Cap $106.46M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$17.33
Range $16.00 – $20.00
Implied Upside
+512.4%
Consensus $17.33 vs current $2.83
NASDAQ·Healthcare·Biotechnology
$2.83
-3.08%
Mkt Cap $106.46M
No recent rating data.
Price Target (3 analysts)
$17.33
Range $16.00 – $20.00
+512.4%
Consensus $17.33 vs current $2.83